Skip to Main Content

Paper Details

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.
Clin Cardiol
36
2018
AMI, C-reactive protein, HF, IL-1, IL-1 receptor, Interleukin-1, MI, Patients, ST-segment elevation myocardial infarction, STEMI, acute myocardial infarction, anakinra, autoimmune/auto-inflammatory diseases, cardiovascular death, chronic, heart failure, kidney disease, malignancy, patients, valvular disease
Author NameAffiliation
Michael C KontosVirginia Commonwealth University
Christine DeWildeVCU Johnson Center for Pulmonary and Critical Care Research, Virginia Commonwealth University
Keyur B ShahVirginia Commonwealth University
  • 1 - 3

Datasets

Release 1.2